Patrick AebischerPatrick Aebischer a achevé une formation en Médecine (1980) et en Neurosciences (1983) aux Universités de Genève et de Fribourg en Suisse.
De 1984 à 1992, Patrick Aebischer a travaillé à Brown University (USA) au sein du Département des Neurosciences et au Département des Biomatériaux et des Organes Artificiels en tant que Professeur assistant, puis Professeur associé.
En 1992, Patrick Aebischer a été nommé Professeur de la Division Autonome de Recherche Chirurgicale et du Centre de Thérapie Génique (DARC) au Centre Hospitalier Universitaire Vaudois (CHUV) à Lausanne.
En 1999, Le Conseil Fédéral a nommé Patrick Aebischer en tant que Président de l'Ecole Polytechnique Fédérale de Lausanne (EPFL). Il a pris ses fonctions à la Présidence de lEPFL en mars 2000, position qu'il a occupée jusqu'au 31 décembre 2016.
Patrick Aebischer est membre de maintes sociétés professionnelles, tant en Europe quaux Etats-Unis.
Patrick Aebischer a fondé trois start-up de biotechnologies. Il siège au conseil d'administration de Lonza, de Logitech et de Nestlé. Il préside également l'advisory board du Novartis Venture Fund. Patrick Aebischer est membre du conseil de fondation du Festival de Jazz de Montreux, du Festival de Verbier et de la Fondation Jacobs.
Les recherches quil poursuit actuellement dans son laboratoire se concentrent sur le développement d'approches de thérapie cellulaire et de transfert génique pour le traitement des maladies neurodégénératives.
Anthony Christopher DavisonAnthony Davison has published on a wide range of topics in statistical theory and methods, and on environmental, biological and financial applications. His main research interests are statistics of extremes, likelihood asymptotics, bootstrap and other resampling methods, and statistical modelling, with a particular focus on the first currently. Statistics of extremes concerns rare events such as storms, high winds and tides, extreme pollution episodes, sporting records, and the like. The subject has a long history, but under the impact of engineering and environmental problems has been an area of intense development in the past 20 years. Davison''s PhD work was in this area, in a project joint between the Departments of Mathematics and Mechanical Engineering at Imperial College, with the aim of modelling potential high exposures to radioactivity due to releases from nuclear installations. The key tools developed, joint with Richard Smith, were regression models for exceedances over high thresholds, which generalized earlier work by hydrologists, and formed the basis of some important later developments. This has led to an ongoing interest in extremes, and in particular their application to environmental and financial data. A major current interest is the development of suitable methods for modelling rare spatio-temporal events, particularly but not only in the context of climate change. Likelihood asymptotics too have undergone very substantial development since 1980. Key tools here have been saddlepoint and related approximations, which can give remarkably accurate approximate distribution and density functions even for very small sample sizes. These approximations can be used for wide classes of parametric models, but also for certain bootstrap and resampling problems. The literature on these methods can seem arcane, but they are potentially widely applicable, and Davison wrote a book joint with Nancy Reid and Alessandra Brazzale intended to promote their use in applications. Bootstrap methods are now used in many areas of application, where they can provide a researcher with accurate inferences tailor-made to the data available, rather than relying on large-sample or other approximations of doubtful validity. The key idea is to replace analytical calculations of biases, variances, confidence and prediction intervals, and other measures of uncertainty with computer simulation from a suitable statistical model. In a nonparametric situation this model consists of the data themselves, and the simulation simply involves resampling from the existing data, while in a parametric case it involves simulation from a suitable parametric model. There is a wide range of possibilities between these extremes, and the book by Davison and Hinkley explores these for many data examples, with the aim of showing how and when resampling methods succeed and why they can fail. He was Editor of Biometrika (2008-2017), Joint Editor of Journal of the Royal Statistical Society, series B (2000-2003), editor of the IMS Lecture Notes Monograph Series (2007), Associate Editor of Biometrika (1987-1999), and Associate Editor of the Brazilian Journal of Probability and Statistics (1987 2006). Currently he on the editorial board of Annual Reviews of Statistics and its Applications. He has served on committees of Royal Statistical Society and of the Institute of Mathematical Statistics. He is an elected Fellow of the American Statistical Assocation and of the Institute of Mathematical Statistics, an elected member of the International Statistical Institute, and a Chartered Statistician. In 2009 he was awarded a laurea honoris causa in Statistical Science by the University of Padova, in 2011 he held a Francqui Chair at Hasselt University, and in 2012 he was Mitchell Lecturer at the University of Glasgow. In 2015 he received the Guy Medal in Silver of the Royal Statistical Society and in 2018 was a Medallion Lecturer of the Institute of Mathematical Statistics.
Jacques FellayJacques Fellay is a medical scientist with expertise in infectious diseases and human genomics. He obtained his MD from the University of Lausanne in 2002 and his PhD from University of Utrecht. After a clinical training in infectious diseases in Switzerland and a 4-years postdoctoral fellowship at Duke University, he joined the EPFL in April 2011 with an SNF Professorship.
On top of his EPFL affiliation, Jacques is also Head of Precision Medicine at the University Hospital (CHUV) in Lausanne, Group Leader at the Swiss Institute of Bioinformatics, and Co-director of the Health2030 Genome Center at Campus Biotech in Geneva.
Anton SchleissProf. Dr. Anton J. Schleiss graduated in Civil Engineering from the Swiss Federal Institute of Technology (ETH) in Zurich, Switzerland, in 1978. After joining the Laboratory of Hydraulic, Hydrology and Glaciology at ETH as a research associate and senior assistant, he obtained a Doctorate of Technical Sciences on the topic of pressure tunnel design in 1986. After that he worked for 11 years for Electrowatt Engineering Ltd. (now Pöyry) in Zurich and was involved in the design of many hydropower projects around the world as an expert on hydraulic engineering and underground waterways. Until 1996 he was Head of the Hydraulic Structures Section in the Hydropower Department at Electrowatt. In 1997, he was nominated full professor and became Director of the Laboratory of Hydraulic Constructions (LCH) in the Civil Engineering Department of the Swiss Federal Institute of Technology Lausanne (EPFL). The LCH activities comprise education, research and services in the field of both fundamental and applied hydraulics and design of hydraulic structures and schemes. The research focuses on the interaction between water, sediment-rock, air and hydraulic structures as well as associated environmental issues and involves both numerical and physical modeling of water infrastructures. In May 2018, he became Honorary Professor at EPFL. More than 50 PhD and Postdoc research projects have been carried out under his guidance. From 1999 to 2009 he was Director of the Master of Advanced Studies (MAS) in Water Resources Management and Hydraulic Engineering held in Lausanne in collaboration with ETH Zurich and the universities of Innsbruck (Austria), Munich (Germany), Grenoble (France) and Liège (Belgium). From 2006 to 2012 he was the Head of the Civil Engineering program of EPFL and chairman of the Swiss Committee on Dams (SwissCOLD). In 2006, he obtained the ASCE Karl Emil Hilgard Hydraulic Price as well as the J. C. Stevens Award. He was listed in 2011 among the 20 international personalities that “have made the biggest difference to the sector Water Power & Dam Construction over the last 10 years”. Between 2014 and 2017 he was Council member of International Association for Hydro-Environment Engineering and Research (IAHR) and he was chair of the Europe Regional Division of IAHR until 2016. For his outstanding contributions to advance the art and science of hydraulic structures engineering he obtained in 2015 the ASCE-EWRI Hydraulic Structures Medal. The French Hydro Society (SHF) awarded him with the Grand Prix SHF 2018. After having served as vice-president between 2012 and 2015 he was president of the International Commission on Large Dams (ICOLD) from 2015 to 2018. On behalf of ICOLD he his the coordinator of the EU Horizon 2020 project "Hydropower Europe". With more than 40 years of experience he is regularly involved as a consultant and expert in large water infrastructures projects including hydropower and dams all over the world. Awards (besides those mentioned above): ASCE-Journal of Hydraulic Engineering Outstanding Reviewer Recognition 2013 ASCE-EWRI-Journal of Hydraulic Engineering 2014 Best Technical Note
Johan AuwerxJohan Auwerx is Professor at the École Polytechnique Fédérale in Lausanne, Switzerland, where he occupies the Nestle Chair in Energy Metabolism. Dr. Auwerx has been using molecular physiology and systems genetics to understand metabolism in health, aging and disease. Much of his work focused on understanding how diet, exercise and hormones control metabolism through changing the expression of genes by altering the activity of transcription factors and their associated cofactors. His work was instrumental for the development of agonists of nuclear receptors - a particular class of transcription factors - into drugs, which now are used to treat high blood lipid levels, fatty liver, and type 2 diabetes. Dr. Auwerx was amongst the first to recognize that transcriptional cofactors, which fine-tune the activity of transcription factors, act as energy sensors/effectors that influence metabolic homeostasis. His research validated these cofactors as novel targets to treat metabolic diseases, and spurred the clinical use of natural compounds, such as resveratrol, as modulators of these cofactor pathways.
Johan Auwerx was elected as a member of EMBO in 2003 and is the recipient of a dozen of international scientific prizes, including the Danone International Nutrition Award, the Oskar Minkowski Prize, and the Morgagni Gold Medal. His work is highly cited by his peers with a h-factor of over 100. He is an editorial board member of several journals, including Cell Metabolism, Molecular Systems Biology, The EMBO Journal, Journal of Cell Biology, Cell, and Science. Dr. Auwerx co-founded a handful of biotech companies, including Carex, PhytoDia, and most recently Mitobridge, and has served on several scientific advisory boards.
Dr. Auwerx received both his MD and PhD in Molecular Endocrinology at the Katholieke Universiteit in Leuven, Belgium. He was a post-doctoral research fellow in the Departments of Medicine and Genetics of the University of Washington in Seattle.
Thomas MountfordD'origine britannique, né en 1961. Il a reçu la bourse présidentielle des jeunes investisseurs (Presidential Young Investigator Grant) en 1990 et le prix de la Fraternité Sloan (Sloan Fellowship) en 1991. Son travail montre que les valeurs critiques d'une classe large de de systèmes de particules proches sont égales à 1, et que, suite à plusieurs travaux sur la trajectoire du mouvement brownien, incluant une simulation numérique, le nombre d'îlots browniens en 2 dimensions tend vers l'infini quand leurs tailles tendent vers 0. Il reçoit le prix Rosenbaum en 1993 lui ouvrant ainsi les portes du Isaac Newton Institute à Cambridge. Il est également décoré par le prix Rollo Davidson en 1995 et nommé membre honoraire de l'Institute of Mathematical Statistics en 2001.
Assistant Profeseur de Mathematique a UCLA 1987- 1991
Associate Professeur de Mathematique a UCLA 1991-1993
Professeur de Mathematique a UCLA 1993-2001
Professeur Departement de mathématiques, EPFL dès 2001
